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Abstract
Correlational data suggest that learned associations are encoded within neuronal ensembles. 
However, it has been difficult to prove that neuronal ensembles mediate learned behaviours 
because traditional pharmacological and lesion methods, and even newer cell type-specific 
methods, affect both activated and non-activated neurons. Additionally, previous studies on 
synaptic and molecular alterations induced by learning did not distinguish between behaviourally 
activated and non-activated neurons. Here, we describe three new approaches—Daun02 
inactivation, FACS sorting of activated neurons and c-fos-GFP transgenic rats — that have been 
used to selectively target and study activated neuronal ensembles in models of conditioned drug 
effects and relapse. We also describe two new tools — c-fos-tTA mice and inactivation of CREB-
overexpressing neurons — that have been used to study the role of neuronal ensembles in 
conditioned fear.
Introduction
In 1949, Hebb proposed that learned associations are encoded within specific patterns of 
neurons called cell assemblies (now called neuronal ensembles) that were selectively 
activated by environmental cues1. Since then, many electrophysiology and cellular imaging 
studies have found correlational evidence that supports the idea that learned associations 
between environmental cues and unconditioned rewards are encoded by neuronal ensembles 
that are activated by these same cues and rewards 2 (Figure 1). The neuronal ensemble 
hypothesis has had a transforming and long-lasting impact on modern neuroscience 
research, and has been the conceptual framework for numerous learning and memory 
studies 2–8. Since the 1950s 9, investigators have primarily used in vivo electrophysiology to 
characterize temporal activity patterns of putative neuronal ensembles in different brain 
areas in learned behaviours 5, 10–13. Since the late 1990s, investigators have also used 
double-labelling methods with immediate-early genes (IEGs) as markers of neural activity to 
characterize the spatial pattern of activated neuronal ensembles in the brain 14–19 (Box 1). 
More recently, in vivo two-photon calcium imaging methods were developed to 
simultaneously record from hundreds of activated neurons 20. These methods, which use 
calcium-sensitive synthetic dyes and genetically encoded calcium indicator proteins 
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(GCaMPs), have been used to record learning-related alterations in the activity of neuronal 
ensembles in head-fixed 21 or freely moving awake behaving mice 22.
Box 1
Immediate early gene-based methods
Over the years, several immediate early gene (IEG)-based methods have been used to 
identify putative neuronal ensembles in the brain34, 130, 131. The general principle has 
been to use one neuronal activity marker to label neurons activated during the initial 
learning session or sessions and a different neuronal marker to label neurons that are 
activated during a subsequent session (which is typically used to assess the expression of 
the learned behaviour). A high level of double-labelling of the two activity markers 
would suggest the recruitment of neuronal ensembles that encode the learned behaviours.
In the late 1990s, Guzowski and colleagues introduced the ‘cellular compartment analysis 
of temporal activity by fluorescence in situ hybridization’ (catFISH) method 14. This 
procedure was based on the temporal characteristics of the IEG arc after neuronal 
activation: a nuclear arc RNA signal emerges 2 min after neuronal activation and persists 
for up to 16 min, whereas a cytoplasmic RNA signal emerges 20–45 min after 
activation 17. Accordingly, in situ hybridization can reveal neurons with cytoplasmic arc 
mRNA, which are neurons that were active earlier (e.g., during the first learning session), 
and neurons with nuclear arc mRNA, which are neurons that were active more recently 
(e.g. during the second learning session)17. Along with a variation on the procedure in 
which the IEG Homer1 is used to label initial neuronal activation and nuclear arc is used 
to label subsequent neuronal activation 112, 132, this method has been used to identify 
putative neuronal ensembles that encode specific cues or contexts. The method is useful 
in identifying neuronal ensembles that are activated during short (about 30 min) learning 
tasks or time intervals between presentations of the same or different stimuli 14, 17. The 
main limitation of the catFISH method is that it cannot be used in learning tasks in which 
the learning and the expression of the learned behaviour are separated by hours or days.
Another IEG-based method is double-labelling of the IEGs c-fos (using in situ 
hybridization) and FosB (using immunohistochemistry). FosB immunoreactivity labels 
neurons that were repeatedly activated during the first training or learning sessions, 
whereas c-fos in situ hybridization labels neurons that were activated during the second 
session. This method is based on the accumulation of long-lasting protein isoforms from 
a truncated fosB splice variant called deltaFosB in repeatedly activated neurons 133. This 
method has been used to identify putative neuronal ensembles in the nucleus accumbens 
in context-specific cocaine locomotor sensitization 15.
In a recently developed approach, a transgenic c-fos-tTA mouse is used to identify 
neuronal ensembles 16, 114. The c-fos-tTA transgene uses the c-fos promoter to induce the 
expression of a tetracycline (tet)-off transcriptional activator (tTA) protein in neurons 
that are activated during the first learning session. The tTA protein can then bind to a tet 
operator in the promoter of a second transgene to induce expression of a marker gene. 
tTA can be induced in activated neurons before and after training, but doxycycline, 
which binds to and represses tTA, can be added to the mouse diet to block expression of 
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the marker gene. If doxycycline is removed from the diet before the mouse undergoes the 
first learning session, the marker gene (e.g., lacZ, histone2B-green fluorescent protein 
(GFP)) can be expressed in neurons that were activated during a selected time window. 
Immunohistochemical labelling of the protein products of zif268 16 or c-fos 116 can be 
used to label neurons that were activated during the second session. The c-fos-tTA tool 
has been used to identify neuronal ensembles that control fear conditioning 16, 19, 33, 116.
An extensive literature, reviewed in the citations above and many other reviews, supports 
the notion that neuronal ensemble activity encodes diverse forms of learned associations that 
mediate learned behaviours. However, until recently this evidence was based only on 
correlations between behaviour and in vivo electrophysiological firing or two-photon 
calcium-imaging patterns during learning and memory tasks or postmortem activity patterns 
of different IEGs. Therefore, a causal involvement of the putative neuronal ensembles in 
learned behaviours had not been established. Until recently, methods aimed at assessing 
such causal roles in behaviour manipulated neuronal activity within specific brain areas — 
such as permanent excitotoxic lesions, reversible inactivation using GABAergic agonists or 
the sodium channel blocker tetrodotoxin, intracranial injections of selective receptor 
antagonists (e.g., dopamine or glutamate receptor antagonists), activation or inhibition using 
optogenetics or DREADD (designer receptors exclusively activated by designer drugs) 23 — 
affect neuronal activity of either all neurons or all neurons of a particular cell type, 
regardless of their activation state during the learned behaviours. Additionally, it had not 
been possible to characterize molecular and electrophysiological alterations within the 
activated neuronal ensembles that presumably mediate memory formation and learned 
behaviours. Indeed, the published literature on synaptic plasticity (as assessed by ex vivo 
slice electrophysiology techniques) and molecular mechanisms of learning and memory are 
based on results obtained from either randomly selected neurons or neurons of a particular 
cell type, independently of their activation state during learned behaviours 24–27.
The goal of this review is to describe several recent technical developments that make it 
possible to determine causal roles of putative activated neuronal ensembles in learned 
behaviours, and to characterize molecular and electrophysiological alterations within the 
activated neurons. We first describe three recently developed tools to study the role of 
neuronal ensembles in conditioned drug effects and relapse in rats. These include the 
Daun02 inactivation method 28, flow cytometry and fluorescence-activated cell sorting 
(FACS) of activated Fos-expressing neurons 29 and c-fos-GFP transgenic rats 30, which can 
be used to selectively inactivate neuronal ensembles and assess molecular and 
electrophysiological alterations within activated neuronal ensembles. We also describe two 
other methods — inactivation of CREB-overexpressing neurons 31, 32 and c-fos-tTA 
mice 16, 19, 33 — that have been used to study the role of neuronal ensembles in conditioned 
fear. These methods all rely on the c-fos gene promoter to manipulate the activity of strongly 
activated neurons and to identify these neurons for subsequent molecular and cellular 
analysis. The c-fos promoter is rapidly induced within strongly activated neurons (see Box 2 
for details) and c-fos mRNA and Fos protein products have been used in numerous papers as 
markers of neuronal activation in many neuronal phenotypes in many brain areas 34–36. 
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Below we describe the different methods, their application to studying learned behaviours, 
and the limitations of each method.
Box 2
The c-fos promoter as a marker of neuronal activity during behaviour
The widespread use of c-fos mRNA and its Fos protein products to identify neuronal 
activation in brain 34–36 has led to many studies that have examined the detailed 
molecular and cellular mechanisms of c-fos promoter activation. The relevant literature is 
immense and is summarized here with only a few selected citations. By necessity, the 
early studies of c-fos and IEG induction were performed under very artificial conditions 
using cell or slice culture. These studies were important for identifying candidate 
signalling mechanisms for IEG induction 34, 134, 135. Many of these mechanisms were 
also shown in the brain during either development, following chemical or mechanical 
damage, or following various manipulations that produced non-physiological activation 
of signal transduction pathways. However, only a few of these mechanisms have a 
significant role in c-fos promoter activation in the brains of intact behaving rats or mice. 
In the striatum and hippocampus, c-fos expression is mediated by ERK/MAPK-
dependent phosphorylation of Elk-1/SRF and CREB on the c-fos promoter 35, 136, 137, 
and not by the cAMP pathway 138, 139. Neuronal activation of the ERK/MAPK pathway 
requires consistent (not sporadic) high levels of calcium influx through NMDA receptors 
and voltage-sensitive calcium channels (VSCCs) 35, 137, 140, 141. Thus, we hypothesize 
that c-fos expression in behaving animals reflects a summation or integration of neuronal 
activity-dependent calcium influx over seconds to minutes, and only strong consistent 
activity over this timeframe will increase calcium levels enough to induce c-fos. 
Glutamatergic excitatory input (along with modulation by GABA inhibitory input) plays 
a major part in inducing strong neuronal activation 35. Drug-induced dopamine release in 
the striatum is often thought to have a direct pharmacological role in activating neuronal 
activity and Fos expression, but this is unlikely because dopamine and dopaminergic 
agonists tend to hyperpolarize striatal neurons in the absence of ongoing glutamatergic 
input 142. Instead drug-induced dopamine release is thought more likely to enhance the 
post-synaptic effect of ongoing glutamatergic input on the most strongly activated 
neurons which increases their neural activity even further 142 to a level sufficient for c-
fos promoter activation 35. In contrast drug-induced dopamine attenuates the effect of 
ongoing glutamatergic input and neural activity of the less activated majority of 
neurons 142.
Previous attempts to directly examine the association between electrophysiological 
activity and Fos expression in striatum and hippocampus have shown that the level of Fos 
expression correlates with the level of synaptic activity and not with the number of action 
potentials 131, 143. However, results from these studies are difficult to interpret in the 
context of Fos-related neuronal ensembles activity, because electrophysiological 
recordings of randomly selected striatal or hippocampal dentate gyrus neurons are almost 
certainly recordings from the majority of (less activated) neurons and not the neurons that 
were activated strongly enough to express Fos. In vivo calcium imaging has recently been 
used to demonstrate a low correlation between spontaneous neuronal activity and Fos 
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expression in single auditory cortex neurons in anaesthetized mice 121. However, these 
negative data are also difficult to interpret in the context of Fos-related neuronal 
ensemble activity, because anaesthesia has been shown repeatedly to block the more 
behaviourally relevant Fos expression induced in awake behaving rodents 144. In the 
future, it will be important to repeat similar studies with in vivo calcium imaging to 
appropriately compare neuronal activity with induced c-fos promoter activation in awake 
behaving rats or mice.
Neuronal ensembles in addiction and relapse
Neuronal ensembles in the nucleus accumbens and prefrontal cortex
Since the 1960s, many studies in humans and laboratory animals have demonstrated that 
classical and operant conditioning mechanisms play a major role in drug use and 
relapse 37–40. With repeated drug use, addicted individuals learn to associate drug effects 
with stimuli or cues in the drug environment (e.g., drug paraphernalia, places of drug taking, 
and co-users), and over time these cues often promote drug craving and drug seeking 39–41. 
Drug-related cues are complex combinations of different stimuli that are recognized with a 
high degree of resolution. Therefore, any neural mechanism capable of encoding these 
learned associations must have a comparably high degree of resolution. It has been proposed 
that neuronal ensembles can provide a mechanistic framework for understanding the 
behavioural and motivational effects of drug-associated cues 15, 42, 43. Indeed, over the past 
two decades, several studies combining drug self-administration procedures 44 with in vivo 
electrophysiology have provided correlative evidence for a role of neuronal ensembles in 
several brain areas (the nucleus accumbens, medial prefrontal cortex (mPFC), ventral 
pallidum and basolateral amygdala) in cue-induced drug seeking 45–50. There is also limited 
correlative evidence from studies that compared context-specific locomotor sensitization 
Cruz et al. Page 5
Nat Rev Neurosci. Author manuscript; available in PMC 2015 August 09.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
behaviour with double-labelling of c-fos mRNA and FosB protein (Box 1) in context-
specific selection of neuronal ensembles in the nucleus accumbens 15.
The neuronal ensemble hypothesis has had some impact on addiction research, but studies 
based on this hypothesis still form only a small proportion of neurobiological research on 
drug addiction. The vast majority of studies on molecular and synaptic plasticity 
mechanisms of drug reward, relapse and conditioned drug effects assess drug- or cue-
induced molecular and cellular alterations in randomly selected neurons or in neurons of a 
particular cell type, independently of their activation state during behaviour in different 
animal models of drug addiction 51–57. Therefore, the alterations assessed in these studies 
were induced largely in the non-activated majority of neurons and not specifically in the 
neuronal ensembles that were selectively activated during the behaviour. The unique drug-
induced or cue-induced molecular and cellular alterations in the minority of activated 
neurons or neuronal ensembles, which presumably mediate drug-seeking behaviour and 
conditioned drug effects, were likely missed or masked by drug-induced alterations in the 
non-activated majority of neurons.
Based on the above considerations, during the last several years we have developed a set of 
pharmacogenetic, molecular biology and genetic tools to selectively inhibit neuronal 
ensembles and assess their unique molecular and synaptic alterations. We developed these 
tools in rats because long-term studies using intravenous drug self-administration 
procedures 44 and animal models of drug relapse and craving 58–60 are technically very 
challenging in mice.
The Daun02 inactivation method
The Daun02 method28 was developed to manipulate only those sparsely distributed neurons 
that are activated by specific stimuli or events without affecting either the surrounding non-
activated neurons or neurons that are activated by other stimuli or events. We applied the 
Daun02 inactivation procedure to selectively inactivate neurons that were previously 
activated by drug-associated cues or contexts 28 (Figure 2). Below we describe the method, 
its application to studying drug-related behaviours, as well as its limitations.
We used c-fos-lacZ transgenic rats, which have a transgene that contains a c-fos promoter to 
induce transcription of the lacZ coding sequence and translation of the protein product β-
galactosidase. This induction occurs only in strongly activated (that is, Fos-positive) 
neurons, but not in the surrounding non-activated or weakly activated (that is, Fos-negative) 
neurons 61–63. Once β-galactosidase is induced in neurons that are activated, these neurons 
can then be inactivated through injection of the inactive prodrug Daun02 28, 64–68. Daun02 is 
catalyzed by β-galactosidase into daunorubicin, which inactivates the previously activated 
neurons through two potential mechanisms: apoptotic cell death 65, 66 or blockade of 
voltage-dependent calcium channels 69. Thus, in our experiments, Daun02 injections disable 
those neurons that were activated by the cue, context or drug and thus presumably the 
neuronal ensemble that encodes the association between the cue or context and the 
drug24, 62, 63. On the test day, typically 3 days after Daun02 injections, we assess whether 
these injections decrease the ability of the drug-associated cues or contexts, or the ability of 
the drug itself, to reactivate the same drug-related neuronal ensemble and induce a 
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conditioned response or drug seeking. A critical control condition that is required to show a 
causal role of neuronal ensembles in the drug-related behaviour is that Daun02 injections 
after exposure to a non-drug-associated cue or context or to a novel context inactivates 
neurons distinct from those in the drug-related neuronal ensemble and should, therefore, 
have no effect on the drug-related behaviour on the test day.
We first used the Daun02 inactivation method 28 to demonstrate a causal involvement for 
neuronal ensembles in the nucleus accumbens in context-specific sensitization of cocaine-
induced locomotion 15, 70, 71. We first demonstrated context-specific activation of 
accumbens neurons by training a group of rats to associate cocaine (7 daily injections) with 
one context (A) and another group of rats to associate cocaine with a different context (B). 
After 7 withdrawal days, we injected rats with cocaine or saline in context A and perfused 
them 90 min later to assess Fos expression in the nucleus accumbens. Cocaine injections in 
test context A enhanced (sensitized) cocaine-induced locomotion and accumbens Fos 
expression in rats that were previously injected with cocaine in the same context A, but not 
in rats that were previously injected with cocaine in the different context B. Double-
labelling immunohistochemistry for Fos and the neuronal marker NeuN showed Fos 
expression in ~3% of accumbens neurons 72. To assess a causal role for this minority of 
activated Fos-expressing neurons in context-specific cocaine sensitization, we trained c-fos-
lacZ transgenic rats to associate context A with cocaine (7 daily injections). After 7 
withdrawal days, we injected separate groups of rats with cocaine in context A or in a novel 
context B, and then injected Daun02 or vehicle into the accumbens 90 min later. Three days 
later, on the test day, we found that prior Daun02 inactivation of accumbens neurons 
attenuated cocaine-induced locomotor sensitization and neuronal activation (assessed by c-
fos promoter-induced β-galactosidase expression) when Daun02 was injected following 
cocaine administration in context A, but not when it was injected following cocaine 
administration in the novel context B 28. Together, these results indicate that context-
specific locomotor sensitization to cocaine is mediated by context-specific selection of 
accumbens neuronal ensembles that are comprised of a small proportion of sparsely 
distributed neurons.
In our second application 67 of the Daun02 inactivation method, we demonstrated a causal 
role for neuronal ensembles in the ventral mPFC in context-induced reinstatement of drug 
seeking, an animal model of relapse induced by exposure to the drug-associated 
environment 73. We first trained rats to self-administer (by lever pressing) heroin in context 
A and extinguished lever pressing in context B. On the test day, 14+ days later, re-exposure 
to the heroin context (A), but not the extinction context (B), increased heroin seeking and 
increased Fos expression in ~6% of the ventral mPFC neurons. To assess a causal role for 
this minority of activated Fos-expressing neurons in context-induced reinstatement, we 
trained c-fos-lacZ transgenic rats to self-administer heroin in context A and extinguished 
lever pressing in context B. On induction day, 14+ days later, separate groups of rats were 
exposed to either the heroin context (A) or the extinction context (B) for 30 min and Daun02 
or vehicle was injected into the ventral mPFC 90 min after the beginning of context 
exposure. On the test day, 3 days later, we found that prior Daun02-induced inactivation of 
the ventral mPFC decreased context-induced reinstatement and neuronal activation when 
Daun02 was injected following exposure to the heroin-associated context (A), but not the 
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when it was injected after exposure to the extinction context (B). Of note, the magnitude of 
inhibition of context-induced reinstatement by Daun02 injections was similar to that 
observed following ventral mPFC injections of a mixture of GABAA and GABAB agonists 
(muscimol and baclofen, respectively) to reversibly inactivate this brain area 5–10 min 
before the reinstatement tests67. Together, these results indicate that a small subset of ventral 
mPFC neurons form neuronal ensembles that encode the learned association between heroin 
reward and the context in which the drug is self-administered.
In our most recent application 68 of the Daun02 inactivation method, we demonstrated a 
causal role for neuronal ensembles in the orbitofrontal cortex (OFC) in incubation of drug 
craving (as indicated by time-dependent increases in cue-induced drug seeking after 
withdrawal from the drug) 74–76. We trained rats to self-administer heroin (6-h/d for 10 d; 
drug infusions were paired with discrete light cue) and assessed cue-induced heroin seeking 
in extinction tests after 1 or 14 days of withdrawal. Cue-induced heroin seeking increased 
from 1 day to 14 days (incubation of heroin craving) and was accompanied by increased Fos 
expression in ~12% of OFC neurons on withdrawal day 14. To assess a causal role for this 
minority of activated Fos-expressing OFC neurons in heroin craving, we trained c-fos-lacZ 
transgenic rats to self-administer heroin. On induction day, 11 days later, we re-exposed 
these rats to the light cue in the heroin-associated context or to a novel context without the 
light cue for 15 min and injected Daun02 or vehicle into OFC 90 min after the beginning of 
context exposure. On the test day, 3 days later, we found that prior Daun02 inactivation of 
OFC neurons decreased cue-induced heroin seeking and OFC neuronal activation when 
Daun02 was injected following re-exposure to the heroin-associated cues, but not when 
Daun02 was injected following exposure to the novel context68. Non-selective inactivation 
of OFC neurons with muscimol and baclofen also decreased cue-induced heroin-seeking on 
withdrawal day 14 (but not on day 1) 68. These results indicate that heroin-cue-activated 
OFC neuronal ensembles play a causal role in persistent responding to heroin cues after 
withdrawal and incubation of heroin craving.
Taken together, the Daun02 inactivation procedure can be used to study the role of neuronal 
ensembles in the motivational effects of drug cues and contexts. However, the method has 
some limitations and unresolved issues. The Daun02 method, like all c-fos promoter-based 
methods, cannot manipulate behaviours that are dependent on a lower level of neuronal 
ensemble activity than that required to activate the c-fos promoter. Additionally, the method 
is limited to brain areas in which Fos and β-galactosidase are highly co-expressed (such as 
the striatum and the mPFC) and cannot be used to assess neuronal ensemble activity in brain 
areas in which co-expression is moderate or low (for example, the thalamus, unpublished 
observations). Furthermore, we have yet to assess a time course for Daun02 inactivation 
beyond three days and do not know the detailed molecular and cellular mechanism involved 
in Daun02 inactivation. If daunorubicin in activated neurons ablates these neurons through 
apoptosis, then some collateral effects of this apoptosis might be expected on the 
surrounding neurons. However, evidence suggests this is unlikely: as shown above, Daun02 
inactivation of neuronal ensembles that were activated by non-paired (B) or novel contexts 
did not decrease lever pressing or neuronal activity in the training context (A) 28, 67, 68; 
additionally, prior Daun02 inactivation of the cocaine-activated nucleus accumbens 
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ensemble in paired context A had no collateral effect on the ability of intra-accumbens 
injections of a cocktail of AMPA+picrotoxin to activate all accumbens neurons 28.
FACS sorting of activated Fos-expressing neurons
The studies described above indicate that selectively activated neuronal ensembles in 
accumbens and cortical areas have a causal role in context-specific sensitization of cocaine-
induced locomotion, context-induced reinstatement of heroin seeking, and incubation of 
heroin craving. Thus, molecular alterations within these neuronal ensembles are likely to 
have unique and important roles in these drug-related learned behaviours. FACS can be used 
to analyze and purify Fos-expressing neurons for molecular analysis. In the flow cytometry 
component of FACS, brain tissue is enzymatically and mechanically dissociated into single 
cells, which are then fluorescently labelled with antibodies and forced to pass single-file 
through a narrow flow cell in a flow cytometer. In the cell-sorting component of FACS, cells 
are sorted as they leave the flow cell according to their light-scattering and 
immunofluorescent characteristics 77–80. We recently developed a FACS-based method to 
assess gene expression in activated Fos-expressing neurons 29, 81 (Figure 3). In this method, 
neurons are identified by labelling with NeuN antibodies, and activated versus non-activated 
neurons are identified according to their labelling with Fos or β-galactosidase antibodies. 
Below we describe the method, its application to studying drug-related behaviours, as well 
as its limitations. We used FACS to purify activated neurons from different brain areas in 
two drug-induced behavioural models: context-dependent cocaine sensitization and 
incubation of heroin craving 29, 68.
In the first study, we assessed unique alterations of cocaine-induced gene expression in 
activated versus non-activated striatal neurons29. We used FACS to purify activated (β-
galactosidase-expressing) neurons 90 min after injections of cocaine in naïve and cocaine-
sensitized c-fos-lacZ transgenic rats rats. We then compared gene expression in these cell 
populations to gene expression in all neurons from control rats that had received saline 
injections 29. Microarray and qPCR analyses indicated several unique alterations for gene 
expression levels of IEGs (markers of activity) and other genes within activated neurons. 
Expression of the IEGs arc, fosB and nr4a3 was higher in activated neurons from cocaine-
injected rats than in non-activated neurons from the same cocaine-injected rats and in all 
neurons from saline-injected rats. Notably, gene expression was similar in the two control 
conditions: non-activated neurons from cocaine-injected rats and all neurons from saline-
injected rats29.
In the second study, we used the method to assess unique alterations of heroin cue-induced 
gene expression in activated versus non-activated neurons following FACS purification of 
activated Fos-expressing neurons from the mPFC and OFC 82. Rats were trained to self-
administer heroin as above and then remained in their home cages for 14–30 days. On the 
test day, we tested half of the rats for cue-induced heroin seeking in an extinction test (a test 
for incubation of craving after prolonged withdrawal) while the other half remained in their 
home cage (no-test rats). qPCR analyses indicated several unique alterations in gene 
expression levels for IEGs and other genes within activated neurons. Cue-induced heroin 
seeking increased the expression of the IEGs arc, fosB, egr1 and egr2 in activated neurons 
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relative to levels in the non-activated neurons from the same ‘test’ rats or in all neurons from 
the ‘no test’ rats 82.
Taken together, in both studies IEGs were induced in activated neurons but not in non-
activated neurons. This finding, along with our immunohistochemical findings 29, 82, 
supports the idea of sparse coding, in which only a small proportion of sparsely distributed 
neurons undergo the molecular and cellular alterations needed to encode conditioned drug 
effects, whereas the surrounding majority of neurons presumably play a much smaller role. 
As many of these IEGs are also transcription factors, it is likely that they can induce further 
alterations of gene expression within activated neurons that may play uniquely important 
roles in learned behaviours mediated by activated neuronal ensembles.
The FACS-based method has several limitations. We can only identify the relevant neuronal 
ensembles following their activation by acute drug or cue exposure on the test day. Thus, we 
cannot assess molecular alterations that were induced in these neurons during self-
administration training prior to acute drug or cue exposure on the test day. In addition, it is 
not possible to manipulate genes selectively in these activated neurons to assess any 
potential causal roles for these genes in behaviour. We are currently developing methods to 
overcome these issues. Additionally, until recently, our FACS-based method required 
pooling the relevant brain areas, such as the striatum and PFC, from 6–10 rats. This makes 
the method less useful for time- and labour-intensive studies that require intravenous surgery 
and many weeks of behavioural training (including studies on mechanisms of drug reward 
and relapse). Furthermore, different sub-regions of striatum and frontal cortex are known to 
have different roles in the behavioural effects of drugs and non-drug rewards, and the cues 
and contexts associated with them 55, 83–85. To address this issue, we recently combined our 
existing FACS method 81 with Arcturus PicoPure RNA Kit and pre-amplification of the 
target genes to assess gene expression from as few as 5 Fos-positive neurons. These 
modifications enable us to reliably measure gene expression changes in a limited number of 
Fos-expressing neurons from a single dorsal striatum of rats injected with saline or 
methamphetamine 86. We are currently using this improved FACS-method to study unique 
molecular alterations in activated Fos-expressing accumbens and dorsal striatum neurons 
using the context-induced reinstatement of drug seeking model.
c-fos-GFP transgenic mice and rats
Alterations in synaptic efficacy, particularly within excitatory synapses, are regarded as the 
main cellular mechanism underlying learning and memory processes 87, 88, including those 
involved in drug addiction 51, 89. However, as discussed above, previous studies examined 
drug-induced or drug–cue-induced global alterations of synaptic efficacy in randomly 
selected neurons, regardless of their activation state.
c-fos-GFP transgenic mice were developed to assess unique electrophysiological 
characteristics of activated Fos-expressing cortical neurons during different behavioural 
states 90–94. These mice can also be used to study unique synaptic alterations in activated 
Fos-expressing neuronal ensembles during learned behaviours; we describe this use below, 
including its application to studying drug-related behaviours and its limitations. The 
transgene of these mice contains a c-fos promoter that induces expression of green 
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fluorescent protein (GFP) to identify activated neurons in brain slice preparations. In our 
experience, confocal microscopy is necessary to visualize GFP-labelled neurons, because 
regular epifluorescence microscopy does not provide adequate sensitivity. Once a GFP-
labelled neuron is identified, infrared differential interference contrast (DIC) microscopy is 
used to perform whole-cell patch electrophysiology.
We have used these cfos-GFP transgenic mice to assess unique synaptic alterations within 
activated neurons in the nucleus accumbens following context-specific cocaine 
sensitization 95. We previously found that activated Fos-expressing neuronal ensembles in 
the nucleus accumbens mediate context-specific sensitization of cocaine-induced 
locomotion 28. The main finding in our study was that cocaine sensitization, but not acute 
cocaine, produced higher levels of ‘silent synapses’ (synapses that contain functional 
NMDA receptors but no functional AMPA receptors 96) in activated (GFP-positive) 
neurons, and not in non-activated or weakly activated (GFP-negative) neurons. Interestingly, 
the silent synapses induced in activated, GFP-expressing neurons appear different from 
those previously observed in randomly selected nucleus accumbens neurons following 
repeated cocaine injections 97, 98. Specifically, NMDA receptors in silent synapses from 
randomly selected neurons were characterized by high levels of the NR2B subunit 98, 
whereas this was not the case for silent synapses in our activated, GFP-positive neurons 95. 
We hypothesize that silent synapses in GFP-positive neurons may be due to AMPA receptor 
endocytosis resulting from strong activation of these neurons. The data from this study95., 
together with the finding described above28, suggest that distinct synaptic alterations are 
induced in the activated nucleus accumbens neurons that mediate context-specific cocaine 
sensitization.
The c-fos-GFP transgenic mouse is an excellent tool for studying unique synaptic alterations 
in activated neuronal ensembles following relatively simple behavioural models used in the 
addiction field, such as locomotor sensitization and conditioned place preference. However, 
transgenic mice are not ideal subjects for complex studies of drug reward and relapse that 
are based on intravenous drug self-administration. For this reason, we developed a c-fos-
GFP transgenic rat using the genetic construct described earlier 30 (Figure 4). In the initial 
neurobiological study with these transgenic rats, we adapted the classic reinstatement model 
of drug relapse 58 to study reinstatement of food seeking as an animal model of relapse 
during dieting 99. We assessed whether stress-induced reinstatement of palatable food 
seeking 100, which is dependent on dorsal mPFC activity 101, 102, is associated with unique 
synaptic alterations in this brain area. We found that reinstatement of food seeking induced 
by the pharmacological stressor yohimbine 103 was associated with reduced AMPAR/
NMDAR current ratios (indicating reduced glutamatergic synaptic efficacy 104) and 
increased paired-pulse facilitation (indicating decreased synaptic glutamate release 105) in 
activated GFP-positive but not non-activated or weakly activated GFP-negative neurons 30.
Taken together, these studies in c-fos-GFP transgenic rats and mice, as well as earlier 
studies 92, 93 demonstrate that these transgenic rodents are suitable for studying unique 
synaptic alterations in the minority of activated neuronal ensembles that presumably control 
learned behaviours. There are, however, several limitations of this approach. One limitation 
is that, as with the FACS procedure, we cannot assess synaptic alterations that were induced 
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in these neurons during training prior to acute drug or cue exposure on test day. Nor can we 
manipulate these altered synaptic mechanisms selectively in activated neurons to assess their 
causal roles in learned behaviours. Another limitation is that combining behavioural studies 
with synaptic physiology of activated neurons is technically challenging, because of the 
difficulties associated with identifying a sufficient number of GFP-positive neurons in a 
slice preparation. This difficulty arises from the fact that only a minority of neurons 
expresses GFP and this expression is transient, lasting only a few hours. Additionally, to 
date, we have only used this approach after pharmacological activation (using cocaine or 
yohimbine) that induces significantly stronger neuronal activation than that induced by 
exposure to drug or food cues. Thus, we have not yet established that c-fos-GFP rats can be 
used for studies of conditioned drug effects and cue-induced relapse to drug or food seeking. 
As is the case with c-fos-lacZ rats, electrophysiological studies with c-fos-GFP rats and 
mice are limited to behaviours that increase neural activity enough to activate the c-fos 
promoter and induce a high level of co-expression of Fos and GFP in the brain areas of 
interest.
Neuronal ensembles in fear conditioning
The neuronal ensembles hypothesis has been the inspiration for many studies on neuronal 
mechanisms of fear conditioning and extinction 13, 106. As in other neuroscience disciplines, 
most published work on this topic was derived from correlational studies between behaviour 
and in vivo electrophysiology 107, 108 or cellular imaging 109–112 (Box 1) methods. Recently, 
investigators have developed two methods to manipulate putative neuronal ensembles and 
examine their causal role in conditioned fear 18, 113. We describe these methods below 
(Figure 5).
Manipulation of neuronal ensembles in c-fos-tTA transgenic mice
In two recent studies, c-fos-tTA transgenic mice 16, 114 were used in combination with 
optogenetic or DREADD methods to examine causal roles of neuronal ensembles in fear 
conditioning 19, 33. As described in Box 1, c-fos induction of the tTA gene is repressed by 
doxycycline in the drinking water prior to learning. Doxycycline is removed before the first 
learning session, allowing tTA to be induced in neuronal ensembles that are activated during 
the learning task. The tTA activator protein can then bind to a tet operator in the promoter of 
a second transgene and drive the expression of this gene only in neurons that were activated 
(Fos-positive) during the learning task. Investigators have used optogenetic or DREADD 
genetic constructs as the second transgenes to selectively reactivate these neurons during 
tests for the expression of fear learning 19, 33.
Liu et al. 19 used the c-fos-tTA transgenic mice to determine causal involvement of 
hippocampal neuronal ensembles in Pavlovian fear conditioning. They tested whether 
reactivation of neuronal ensembles in the dentate gyrus that were activated during learning 
was sufficient for fear memory recall, operationally defined as increased freezing. The 
experimental group of consisted of c-fos-tTA mice that were injected with an adeno-
associated virus (AAV) expressing ChR2-EYFP and implanted with an optical fibre in the 
dentate gyrus. Mice were kept on doxycycline during habituation days, so that their basal 
freezing levels in context A could be determined during light-off and light-on epochs of 
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optical stimulation. The mice showed little freezing during these habituation sessions prior 
to fear conditioning. Mice were then taken off doxycycline and underwent tone (CS)–shock 
(UCS) pairing (fear conditioning) in context B to induce ChR2 expression in Fos-positive 
neurons that were activated during fear conditioning. Mice were given doxycycline again 
and tested during light-off and light-on epochs in context A. ChR2 activation by optical 
stimulation induced reactivation of the neurons that had previously been activated during 
fear conditioning in context B and produced increased freezing behaviour in context A. In an 
important control condition, after habituation with doxycycline in context A, the authors 
removed doxycycline and induced ChR2 in neuronal ensembles activated by exposure to a 
novel context C in the absence of fear conditioning. Doxycycline was then given to the mice 
before fear conditioning in context B. ChR2-induced activation of context C-related 
ensembles in these mice did not produce higher levels of freezing in context A, presumably 
because this ensemble was not associated with fear conditioning19.
The results of this elegant study 19 suggest a causal role for dentate gyrus neuronal 
ensembles in the formation of stable fear memories. This conclusion would be strengthened 
if it could be shown that halorhodopsin-dependent inhibition of the neuronal ensembles that 
were previously activated during fear conditioning in context B (and that presumably encode 
the fear memory) prevent tone-cue-induced freezing in context B. In other words, although 
the authors showed that activation of dentate gyrus neuronal ensemble is ‘sufficient’ for 
reactivating a fear memory, it is unknown whether endogenous activity of this putative 
ensemble is ‘necessary’ for encoding the fear memory.
In a second study, Garner et al. 33 used the c-fos-tTA transgenic mice with DREADD 
technology to activate Fos-expressing fear-encoding neurons in the brain. These transgenic 
mice have two transgenes that are widely expressed in many brain areas. The first transgene 
is the c-fos-tTA described above. The second transgene contains a tet operator that drives 
tTA-dependent expression of hM3Dq, an artificial Gq-coupled receptor that binds the drug 
clozapine-N-oxide (CNO), which is typically injected systemically to activate neurons 
expressing this receptor 115. One of the experiments of this study33 was similar to that used 
in the earlier study 19. Specifically, doxycycline was removed for 2 days, after which mice 
underwent fear conditioning training in context B, so that the hM3Dq protein was induced in 
neurons that were activated during the fear conditioning. On the test day, the mice were 
placed in a novel context (A) and CNO was systemically injected to activate hM3Dq and 
thereby reactivate those neurons that were previously activated during fear conditioning in 
context B. However, CNO did not induce freezing in context A, suggesting that DREADD-
mediated reactivation of neurons paired with fear conditioning was not sufficient to recall 
the fear memory. The authors also performed several experiments suggesting that co-
activation of artificially induced neuronal ensembles can interfere with naturally produced 
cue-activated neuronal ensembles. It is beyond the scope of this article to describe these 
other experiments, because they did not directly test a causal role for neuronal ensembles in 
conditioned fear.
The reasons for the different results between the two studies19, 33 are unknown. Optogenetic 
activation of neurons may be stronger than DREADD-based activation of neurons. Beyond 
methodological differences related to the fear conditioning procedures, a very important 
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difference is that one study 19 reactivated neuronal ensembles in only the dentate gyrus, 
whereas the other 33 reactivated ensembles in multiple brain areas, which may interfere or 
mask the expression of conditioned fear. Finally, it should be noted that in a different 
study116 using c-fos-tTA mice, the number of tTA-induced GFP-expressing hippocampal 
neurons was less than the number of Fos-expressing neurons following context-induced 
reactivation of fear on test day. This finding suggests that tTA activation in other studies 
using c-fos-tTA mice may underestimate the number of neurons that are activated during 
fear conditioning.
Inactivation of CREB-overexpressing neurons
Viral overexpression of CREB combined with diphtheria toxin or activation of allatostatin 
receptors for subsequent inactivation of CREB-overexpressing neurons has been proposed 
as a method to study neuronal ensembles in lateral amygdala in fear conditioning 31, 32. Han 
et al. 4 used herpes simplex virus (HSV) to overexpress both CREB and Cre recombinase 
transgenes from the same viral construct in a small number of lateral amygdala neurons in 
transgenic mice carrying a Cre-inducible diphtheria toxin receptor (DTR) transgene. 
Subsequent injections of diphtheria toxin (which binds to DTR) can then selectively 
inactivate neurons that express DTR 31. In the first phase of the experiment, test mice that 
overexpressed CREB and DTR in the same neurons and control mice that overexpressed 
DTR but not CREB underwent fear conditioning in what was termed weak (one tone–shock 
pairing) or strong (two tone–shock pairings) training in one context. All mice were tested 
one day later for expression of fear conditioning (freezing) in a different context. Similar to 
results in a previous study 117, CREB overexpression in the test mice increased neural 
responsiveness of the CREB-overexpressing neurons, which leads to their preferential 
activation during fear learning and enhanced fear expression in the weak but not strong 
training condition (presumably the strong training condition already produced maximal 
levels of fear learning) 31. In the subsequent lesioning phase of the experiment, control and 
test mice were injected systemically with diphtheria toxin to ablate DTR-expressing neurons 
and subsequently tested for expression of fear conditioning. Diphtheria toxin reduced the 
expression of fear memory in test mice but not in control mice, in which a similar number of 
lateral amygdala neurons overexpressing DTR (but not CREB) were inactivated by 
diphtheria toxin.
In second study, Zhou et al. 32 used a similar strategy. They used HSV to overexpress both 
CREB and the inhibitory drosophila allatostatin receptor (which is not expressed in rodents) 
in the same neurons; the peptide allatostatin binds to this receptor to reversibly inactivate 
neurons. The authors used experimental methods similar to those described above 31 to 
demonstrate that following auditory fear learning, inactivation of CREB-overexpressing 
neurons by allatostatin decreased the expression of conditioned fear32.
Although these two studies successfully inactivated CREB-overexpressing neurons and 
decreased the expression of conditioned fear, the CREB overexpression method is not 
optimal for studying causal roles for neuronal ensembles in learned behaviours. This is 
because the ‘neuronal ensembles’ that are inactivated by this method are artificially selected 
CREB-sensitized neurons rather than neuronal ensembles that were naturally selected by cue 
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or context exposure during fear conditioning training. That is, the neurons overexpressing 
CREB in these experiments are randomly selected during HSV infection, prior to any 
learning experience. CREB over-expression in these neurons results in the formation of a 
hypersensitive cell type with synaptic alterations that make them highly responsive to many 
stimuli 97, 118, 119. This leads to the formation of artificial ‘neuronal ensembles’ that 
probably have a very different composition than the putative endogenous neuronal 
ensembles that would be selected during the same learning experience. For comparison, in 
the c-fos promoter-based neuronal ensemble inactivation methods described above, only the 
neurons that are strongly activated by cues, contexts or drugs during learning are selected for 
subsequent inactivation. A promising future direction would be to combine the diphtheria 
toxin or allatostatin inactivation methods with c-fos promoter selection of neurons activated 
during learned behaviours.
Conclusions and future directions
We have discussed recent technical developments that make it possible to determine causal 
roles of putative activated neuronal ensembles in learned behaviours and to characterize 
molecular and synaptic physiology of the activated neurons. These methods are unique and 
largely orthogonal to current mainstream neuroscience research that followed the 
introduction of optogenetic- and DREADD-based methods to the field 23, 27. This is because 
the goal of most optogenetic and DREADD studies is to identify causal roles of specific cell 
types, receptors or cellular signalling molecules in a given brain area or a particular cell-
specific projection in learned behaviour, independently of the activation state of the neurons.
The study of the causal involvement of neuronal ensembles in drug addiction and fear is in 
its infancy, and as discussed above, each method has its own limitations. The only relatively 
clear-cut demonstration of causal roles of endogenous neuronal ensembles in learned 
behaviours has come from studies using the Daun02 inactivation procedure, in which 
inhibition of a small proportion of activated neurons in the nucleus accumbens or cortex 
inhibited context-specific cocaine locomotor sensitization, context-induced reinstatement of 
heroin seeking, and incubation of heroin craving 28, 67, 68. By contrast, as discussed above, 
studies combining optogenetic or DREADD methods with c-fos-tTA mice either only 
demonstrated the ‘sufficiency’ (but not the necessity) of neuronal ensembles in conditioned 
fear 19 or did not provide clear evidence for a role of neuronal ensembles in fear 
conditioning 33. Additionally, although studies using CREB overexpression demonstrated 
that selective inactivation of a small proportion of activated neurons decreases the 
expression of fear conditioning 32, 117, the neurons to be activated during fear learning and 
subsequently inactivated were pre-selected by the HSV viral manipulation. Thus, the 
neuronal ensembles identified in these studies may not reflect the composition of the 
endogenous amygdala neuronal ensembles that are normally selected by the learning 
experience.
There are also important limitations in the methods that have been developed for examining 
molecular 29, 81 and synaptic physiology 30, 95 alterations that were induced in neuronal 
ensembles activated during prior learning or on test day. One main limitation is that we 
cannot assess the basal conditions of the putative neuronal ensembles prior to activation, 
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because we must acutely induce GFP, β-galactosidase or Fos to identify the activated 
neurons. Thus, we cannot determine whether any observed alterations are due to prior 
learning during the training phase or due to acute expression of the learned behaviour on the 
test day. To solve this problem we need to identify neurons that are ‘destined’ to be 
activated and participate in an ensemble, prior to their activation on test day. The second 
limitation is that although we can potentially demonstrate causal roles of selectively 
activated neurons in learned behaviours, there are no tools to manipulate the molecular and 
synaptic alterations induced selectively in the activated neurons to demonstrate how these 
molecular or synaptic alterations affect learned behaviours or cell function. A third 
limitation is that the c-fos promoter-based techniques described above cannot identify 
groups of neurons that are inhibited or insufficiently activated by cues for c-fos promoter 
activation to occur. Therefore, an absence of c-fos activation in neurons does not necessarily 
imply that they were not active and have no role in the behaviour.
It may be possible to overcome the first limitation regarding basal conditions by using the c-
fos-tTA mouse system or our recently developed c-fos-tet-Cre recombinase transgenic rat 
system (unpublished data; FCC, YS, BTH) in which previously activated neurons can be 
identified with a constitutively expressed molecular marker (e.g., GFP) that persists for 
many days after the last manipulation when basal conditions are re-established. A similar 
strategy for identifying previously activated neurons involves tamoxifen-sensitive Cre 
recombinase induced by either the c-fos or arc promoter 120. Additionally, a recent and 
promising technology uses transgenic mice with photoactivable GFP that, once activated, 
can be placed in a long-lasting fluorescent state that permit neurons to be identified at a later 
time for more detailed analysis using slice electrophysiology 121. One study 122 has recently 
achieved selective manipulations within activated neurons by using transgenic mice carrying 
both c-fos-tTA and GFP-GluA1 transgenes 123. The authors used the GFP–GluA1 construct 
to assess structural changes in dendritic spines in hippocampal neurons that were activated at 
the time of fear learning. The main finding was that spines on active (Fos-positive) but not 
those on inactive (Fos-negative) neurons of context-fear-conditioned mice were reduced 24 
h after conditioned fear training, and this reduction did not occur in control mice (exposed to 
the context along or to an unpaired shock). To date, however, none of the published 
techniques described above have been used to define the interactions between neuronal 
ensembles in different brain areas that are active at the same time during learning and on test 
day that may form the circuitry underlying learned behaviour. It will also be important to 
expand on the present work using other activity-dependent promoters such as for arc, which 
has been used for two-photon imaging of integrated neural activity in arc-GFP mice 124, as 
well as for inducing Cre recombinase in activated neurons 120. The arc promoter is similar 
to the c-fos promoter, but generally has higher levels of basal activity and a lower threshold 
for activation 125.
Finally, it is perhaps too early to speculate about the clinical implications of a better 
understanding of the unique molecular and synaptic physiology alterations in behaviourally 
activated neuronal ensembles. Nevertheless, one potential implication is the shift in direction 
of medication development — from strategies that target specific receptor, cell type or 
signalling mechanism that are independent of the neuron’s activity status, to strategies that 
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target specific mechanisms that are observed only in activated neuronal ensembles. For 
example, drugs like ketamine or memantine that bind preferably to activated NMDA 
receptors 126–128 can be used to potentially erase (via interference with memory 
reconsolidation 26, 129) or diminish the motivational impact of memories of drug-associated 
or fear-associated cues. Thus, giving ketamine or memantine immediately after exposing 
drug users or PTSD patients to drug- or trauma-associated cues to reactivate neuronal 
ensembles that encode the drug- or trauma-associated memory may diminish the 
motivational impact of these cues and decrease relapse.
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Figure 1. Neuronal ensembles in the mesocorticolimbic dopamine reward system
Hypothetical schematic of how drug-associated stimuli activate specific patterns of neurons 
or neuronal ensembles in this brain system. Environmental stimuli (e.g., tones, lights, 
odours) and drug-induced interoceptive stimuli (e.g., heart rate, blood vessel tone) during 
drug self-administration activate specific neuronal ensembles in sensory regions of the 
neocortex and olfactory bulb that in turn activate specific neuronal ensembles in the 
prefrontal cortex, hippocampus, basolateral amygdala (BLA), and thalamus. Activated 
principal (glutamatergic) neurons in each brain area are indicated with red circles and non-
activated principal neurons are indicated by light blue circles. Neurons in the nucleus 
accumbens that receive the highest levels of convergent excitatory glutamatergic input (blue 
lines) from these latter brain areas are selectively activated to form a neuronal ensemble that 
corresponds to or encodes the specific combination of stimuli and their relationships on the 
basis of past experience. Depending on the salience and reward value of these stimuli, the 
ventral tegmental area (VTA) sends dopaminergic input (red lines) to the prefrontal cortex 
and nucleus accumbens that further enhances ongoing activity of the more highly activated 
neuronal ensembles while attenuating activity in the less activated majority of neurons in the 
prefrontal cortex and nucleus accumbens. Yellow lines indicate GABAergic outputs from 
the nucleus accumbens to the ventral pallidum (VP) and VTA. CeA, central nucleus of the 
amygdala.
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Figure 2. The Daun02 inactivation method
(A) The c-fos-lacZ transgene in the transgenic rats contains a c-fos promoter that regulates 
transcription of the lacZ coding sequence. Sufficiently strong and persistent neural activity 
induces fos expression and, subsequently, activates the c-fos promoter. As a result, the 
expression of lacZ mRNA and its protein product β-galactosidase is increased in these 
strongly activated neurons but not in the surrounding majority of neurons. The prodrug 
Daun02 is injected into the brain area of interest and is initially inactive. However, β-
galactosidase catalyzes Daun02 to the active product Daunorubicin that induces apoptosis 
and cell death in only those neurons that were activated strongly enough during behaviour to 
induce β-galactosidase. (B) The general experimental procedure requires repeated exposures 
in one context (context A) during the training phase, followed by withdrawal/abstinence or 
extinction in a different context (context B). On the induction day, specific neuronal 
ensembles can be reactivated by the training, extinction or exposure to a novel context 
(context C), along with cues and/or the drug to induce β-galactosidase. Vehicle or Daun02 is 
injected 90 minutes later (the time of maximal β-galactosidase protein induction after 
neuronal activation). On the test day, 3 days later, reactivation of these neurons and 
behavioural effects in the training context (context A) are assessed.
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Figure 3. FACS sorting of activated neurons
The FACS method is used for assessing unique molecular alterations within activated versus 
non-activated neurons. (A) In flow cytometry, including FACS, single cells are 
enzymatically dissociated from brain tissue and fluorescently labeled with different 
antibodies. Labelled samples are then forced to pass single file through a narrow flow cell. 
Absorbance of transmitted laser light for each particle is called Forward Scatter (FSC) light, 
whereas light scattered at a 90-degree angle is called Side Scatter (SSC) light. Each particle 
(cell or non-cell) is called an ‘event’. (B) Each event is indicated by a black dot in the 
Scattergram. The cluster of events in the lower part of the Scattergram corresponds to 
neurons that were subsequently selected (or ‘gated’) by the indicated triangle for further 
analyses of their fluorescence characteristics. Positively labelled events (e.g., Fos-positive 
cells) have high fluorescence levels (red circles), whereas negatively labelled events (e.g., 
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Fos-negative cells) have low fluorescence levels (black circles). (C) These events are 
displayed in a Fluorescence scattergram. Rectangular gates are used to select positive events 
(e.g., Fos-positive and NeuN-positive cells) and negative events (e.g., Fos-negative and 
NeuN-positive cells) for collection using FACS. Droplets containing gated events can be 
programmed to receive an electric charge as they leave the flow cell. Magnetic plates direct 
the charged droplets and sort them into separate ‘positive’ or ‘negative’ sample tubes for 
further molecular analysis.
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Figure 4. Electrophysiology of activated neurons using the c-fos-GFP rat
Assessing unique electrophysiological alterations within activated versus non-activated 
neurons. The cfos-GFP transgene in transgenic rats (or mice) contains a c-fos promoter that 
regulates transcription of the coding sequence for green fluorescent protein (GFP). 
Sufficiently strong and persistent neural activity activates the c-fos promoter which induces 
GFP in these strongly activated neurons but not in the surrounding majority of neurons. (A) 
Coronal slices are obtained for electrophysiological analysis. (B) GFP expression (induced 
by drug or cue exposure) can be used to guide the electrode to GFP-positive or GFP-
negative neurons and attach it using differential interference contrast (DIC) optics. The 
arrow indicates a GFP-positive neuron with the shadow of the attached electrode to the right. 
(C) Alexa 568 in the electrode can diffuse into the attached cell to confirm that recorded cell 
was GFP-positive.
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Figure 5. Manipulating activated fear-encoding neuronal ensembles in the hippocampus and 
amygdala
(A) The c-fos-tTA transgene in transgenic mice contains a c-fos promoter that regulates 
transcription of the coding sequence for the tet-off transcriptional activator (tTA) protein. 
Sufficiently strong and persistent neural activity during a particular learned behaviour 
induces tTA in these strongly activated neurons but not in the surrounding majority of 
neurons. Doxycycline provided to the mice (commonly through the diet) inactivates tTA 
transcriptional activity. When doxycycline is removed from the diet, the tTA can bind to the 
tet operator and activate a second transgene (viral or genomic) that expresses the optogenetic 
activating protein channel rhodopsin-2 (ChR2) or the pharmacogenetic inactivating 
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DREADD receptor (hM3Dq) in those neurons that were previously activated during the 
behaviour. Blue light activates and manipulates the ChR2-expressing neurons, whereas 
clozapine-N-oxide (CNO) activates hM3Dq-expressing neurons that were activated (red) 
during subsequent behavioural tests. (B) A herpes simplex virus (HSV) transgene contains a 
constitutively activated HSV IE4/5 promoter that drives the expression of two genes 
encoding GFP-CREB fusion protein and Cre recombinase, separated by an internal 
ribosome entry site (IRES) (cds indicates coding DNA sequence). Over-expression of GFP-
CREB increases the sensitivity of neurons to synaptic input (red circles). Cre recombinase in 
the same neurons recognizes loxP DNA sequences in the DTR transgene of transgenic mice 
to cut out the Stop DNA sequence; this permits constitutive rosa26 promoter-induced 
expression of diphtheria toxin receptor (DTR) protein. Subsequent injections of Diphtheria 
toxin ablate DTR-expressing neurons. (C) A herpes simplex virus (HSV) transgene contains 
two separate genes: one uses a constitutively activated HSV IE4/5 promoter to drive the 
expression of the gene encoding GFP-CREB fusion protein, and the other gene uses a 
cytomegalovirus immediate early gene promoter (CMV) to drive expression of the gene 
(Alstr) that encodes the drosophila Allatostatin receptor. The same neurons (red circles) 
over-express GFP-CREB, which increases both the sensitivity of neurons (red circles) and 
the expression of the Allatostatin receptor. Subsequent site-specific injections of the 
Allatostatin peptide can inactivate these neurons during a behavioural test.
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